Methods and compositions for treatment of erectile dysfunction

Details Methods and compositions for treatment of erectile dysfunction Methods and compositions for treatment of erectile dysfunction

2008-07-29

2008-07-29

Hui, San-ming (Department: 1617)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S396000, C514S573000, C514S319000

Reexamination Certificate

active

10351049

ABSTRACT:
Disclosed are methods and compositions for treatment of male sexual dysfunction. A method of treating male sexual dysfunction includes administering a pharmaceutical composition effective to cause said male to sustain an erection. The composition is formulated based on diagnostic assessment and an individualized formulation test step. Also within the invention is a method of treating male sexual dysfunction in a population of subjects. The invention further provides kits for treatment of male erectile dysfunction.

REFERENCES:
patent: 4127118 (1978-11-01), Latorre
patent: 5145852 (1992-09-01), Virag
patent: 5256652 (1993-10-01), El-Rashidy
patent: 6127363 (2000-10-01), Doherty et al.
patent: 6200591 (2001-03-01), Hussain et al.
patent: 6300335 (2001-10-01), Campbell et al.
patent: 6303135 (2001-10-01), Cutler
patent: 6323211 (2001-11-01), Garvey et al.
patent: 6323241 (2001-11-01), Yeager et al.
patent: 6333330 (2001-12-01), Bunnage et al.
Abbott and Hirsch, International Journal of Impotence Research, 1997;9:39-42.
Harrison's Principles of Internal Medicines, 13th ed., 1994, pp. 263-265.
Bechara, A, Casabe A, Cheliz, G, Romano S and Fredotovich N., Prostagladin E1 Versus Mixture of Prostagladin E1, Papaverine and Phentolamine in Nonresponders to High Papaverine Plus Phentolamine Doses,The Journal of Urology, vol. 155(3), 913-914. (Mar. 1996).
Truss et al., “Intracavernous pharmacotherapy,” Abstract, World Journal of Urology, 15:71-77, 1997.
Lue et al., “Functional evaluation of penile arteries with duplex ultrasound in vasodilator-induced erection,” Abstract, Urological Clinics of North America, 16:799-807, 1989.
Supplemental Partial Search Report, dated Mar. 17, 2005 (attached to Communication from the European Patent Office, dated Mar. 30, 2005).
“Three-Year Outcome of a Progressive Treatment Program for Erectile Dysfunction with Intracavernous Injections of Vasoactive Drugs,” J. Baniel, et al.,Urology, 56 (4), 2000.
“Clinical Reliability of Multi-Drug Intracavernous Vasoactive Pharmacotherapy for Diabetic Impotence,” F. Montorsi, et al.,Acta Diabetol, 31:1-5, 1994.
“Effectiveness and Safety of Multidrug Intracavernous Therapy for Vasculogenic Impotence,” F. Montorsi, et al.,Urology, vol. 42, No. 5, Nov. 1993.
“Progressive Treatment of Erectile Dysfunction with Intracorporeal Injections of Different Combinations of Vasoactive Agents,” J. Shmueli, et al., International Journal of Impotence Research, 11, 15-19, (1999).

Affiliated with

Also associated with

Rating

Methods and compositions for treatment of erectile dysfunction does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods and compositions for treatment of erectile dysfunction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treatment of erectile dysfunction will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3926546